Literature DB >> 2459959

A comparison of three different methods for the determination of estrogen receptors in human breast cancer.

T J Cudahy1, B R Boeryd, B K Franlund, B A Nordenskjöld.   

Abstract

Forty-seven cases of breast cancer were analyzed for estrogen receptors (ERs) by three different techniques: (1) a biochemical assay using isoelectric focusing in polyacrylamide gel; (2) a monoclonal ER immunocytochemical assay (ERICA, Abbott Laboratories Diagnostics Division), and (3) a polyclonal antiestradiol immunohistochemical technique using formalin-fixed tissue. A high level of agreement (85%) was noted between the biochemical assay and ERICA. The ERICA-processed slides showed minimal background staining and were easy to interpret. Compared with the biochemical assay, ERICA achieved a positive predictive value of 86% and a negative predictive value of 82%. In contrast, results from the polyclonal antiestradiol histologic technique did not correlate with biochemical results and showed positive and negative predictive values of 61% and 25%, respectively. The authors conclude that the ERICA technique should prove to be a valuable adjunct to traditional biochemical ER assays.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459959     DOI: 10.1093/ajcp/90.5.583

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Immunohistological study of oestrogen receptors in breast carcinomas that are biochemically receptor negative.

Authors:  S Shousha; T Stamp; K R James; J Alaghband-Zadeh
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

2.  Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods.

Authors:  A Molino; R Micciolo; M Turazza; F Bonetti; Q Piubello; A Corgnati; L Sperotto; G Martignoni; A Bonetti; R Nortilli
Journal:  Breast Cancer Res Treat       Date:  1995-06       Impact factor: 4.872

3.  Expression of epidermal growth factor receptor (proto-oncogene c-erbB-1) and estrogen receptor in human breast carcinoma. An immunocytochemical study of 70 cases.

Authors:  C Garcìa Castro; M Ravina; V Castro; E C Salido
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.